Jennifer L Whitwell Selected Research

2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)

1/2020	MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous.
1/2020	Longitudinal Amyloid-β PET in Atypical Alzheimer's Disease and Frontotemporal Lobar Degeneration.
1/2018	Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease.
1/2018	Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
11/2014	APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia.
3/2014	Progranulin-associated PiB-negative logopenic primary progressive aphasia.
12/2013	Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jennifer L Whitwell Research Topics

Disease

52	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 04/2007
42	Atrophy 05/2024 - 01/2006
21	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 03/2024 - 01/2004
19	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 04/2024 - 06/2006
14	Frontotemporal Dementia (Semantic Dementia) 03/2024 - 11/2006
13	Tauopathies 05/2024 - 09/2015
13	Dementia (Dementias) 01/2022 - 04/2007
10	Apraxias (Dyspraxia) 04/2024 - 05/2010
10	Aphasia (Dysphasia) 01/2024 - 12/2013
9	Parkinsonian Disorders (Parkinsonism) 04/2024 - 02/2016
9	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 04/2007
9	Cognitive Dysfunction 01/2024 - 12/2008
9	Primary Progressive Aphasia 12/2019 - 05/2010
7	Corticobasal Degeneration 11/2020 - 06/2006
5	Disease Progression 01/2021 - 07/2008
3	Proteostasis Deficiencies 04/2024 - 01/2020
3	Memory Disorders (Memory Loss) 12/2023 - 01/2014
3	Pick Disease of the Brain (Pick's Disease) 11/2020 - 09/2005
3	Hippocampal Sclerosis 01/2020 - 01/2017
2	Lewy Body Disease (Lewy Body Dementia) 01/2021 - 05/2020
2	Amyloid Plaque 01/2019 - 07/2008
2	Language Disorders (Language Disorder) 11/2014 - 03/2014
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2014 - 03/2012
1	Demyelinating Diseases (Demyelinating Disease) 01/2023
1	Vascular Diseases (Vascular Disease) 01/2022
1	Neuroinflammatory Diseases 01/2021
1	Anomia (Dysnomia) 01/2021
1	Meningioma (Meningiomas) 12/2017
1	Psychotic Disorders (Schizoaffective Disorder) 05/2016
1	Seizures (Absence Seizure) 05/2016
1	Neoplasms (Cancer) 05/2016
1	Paralysis (Palsy) 02/2016
1	Pseudobulbar Palsy 02/2016
1	Parkinson Disease (Parkinson's Disease) 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 01/2012
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2008
1	Epilepsy (Aura) 08/2008
1	Multiple Sclerosis 08/2008
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2006

Drug/Important Bio-Agent (IBA)

27	Amyloid (Amyloid Fibrils)IBA 03/2024 - 01/2013
25	Biomarkers (Surrogate Marker)IBA 03/2024 - 07/2008
23	DNA-Binding Proteins (DNA Binding Protein)IBA 05/2024 - 01/2012
21	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2024 - 12/2017
19	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2004
14	Amyloid beta-PeptidesIBA 05/2023 - 02/2008
10	Apolipoproteins E (ApoE)IBA 01/2023 - 11/2014
8	ApolipoproteinsIBA 01/2023 - 01/2014
7	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 05/2010
7	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2020 - 12/2013
6	UbiquitinIBA 02/2008 - 09/2005
5	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2023 - 01/2009
4	IronIBA 01/2023 - 01/2022
4	ProgranulinsIBA 01/2015 - 03/2007
3	LigandsIBA 01/2019 - 07/2017
2	Prostaglandins FIBA 04/2024 - 01/2020
2	tau Proteins (tau Protein)IBA 01/2024 - 01/2004
2	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 07/2017
2	Protein Isoforms (Isoforms)IBA 01/2022 - 10/2021
2	SynucleinsIBA 01/2022 - 01/2021
2	Levodopa (L Dopa)FDA LinkGeneric 01/2019 - 02/2016
2	alpha-SynucleinIBA 01/2017 - 09/2005
1	Glial Fibrillary Acidic ProteinIBA 03/2024
1	neuromelaninIBA 01/2023
1	Cholinergic Agents (Cholinergics)IBA 01/2023
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Neuroprotective AgentsIBA 10/2021
1	ioflupaneIBA 09/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 09/2020
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 09/2020
1	aspartyl- arginyl- valyl- tyrosyl- isoleucyl- histidyl- prolyl- phenylalanyl- histidyl- leucyl- valyl- isoleucyl- histidine (hTDP)IBA 05/2020
1	Apolipoprotein E4IBA 01/2017
1	SteroidsIBA 05/2016
1	PrionsIBA 04/2016
1	AD 20 (AD-20)IBA 03/2011
1	DNA (Deoxyribonucleic Acid)IBA 01/2009
1	N 30IBA 01/2009
1	Protons (Proton)IBA 12/2008
1	CreatineIBA 07/2008
1	N-acetylaspartate (N-acetyl aspartate)IBA 07/2008
1	HydrogenIBA 07/2008
1	Inositol (Myoinositol)IBA 07/2008

Therapy/Procedure

6	Therapeutics 01/2024 - 04/2008
1	Activities of Daily Living (ADL) 01/2016
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 12/2011